In AEL there was a specific and statistically significant association of biallelic CEBPA mutation to GATA2 ZnF1 mutation, as well as a higher incidence of GATA2 ZnF1 mutation compared with non-AEL AML (Ping et al., 2017). This evidence concerns the gene GATA2 and acute erythroid leukemia.